Influence of sex hormones on plasma endothelin levels.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMID 8439117)

Published in Ann Intern Med on March 15, 1993

Authors

K H Polderman1, C D Stehouwer, G J van Kamp, G A Dekker, F W Verheugt, L J Gooren

Author Affiliations

1: Free University Hospital, Amsterdam, The Netherlands.

Articles citing this

The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag (2009) 1.90

Postmenopausal hypertension. Am J Hypertens (2011) 1.22

Hypertension: what's sex got to do with it? Physiology (Bethesda) (2013) 1.09

Hypertension in postmenopausal women. Curr Hypertens Rep (2012) 1.07

Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response. Br J Pharmacol (2014) 0.97

Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity. Hypertension (2009) 0.97

Adverse childhood experiences are associated with detrimental hemodynamics and elevated circulating endothelin-1 in adolescents and young adults. Hypertension (2014) 0.93

Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women. Am J Physiol Heart Circ Physiol (2008) 0.92

Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome. J Physiol (2011) 0.90

Tendency to angry rumination predicts stress-provoked endothelin-1 increase in patients with coronary artery disease. Psychosom Med (2010) 0.89

Depression predicts elevated endothelin-1 in patients with coronary artery disease. Psychosom Med (2010) 0.88

Endothelin-1 and prevalent coronary heart disease in older men and women (the Rancho Bernardo Study). Am J Cardiol (2006) 0.86

Sex differences in response to tadalafil in pulmonary arterial hypertension. Chest (2015) 0.85

Vascular endothelium derived endothelin-1 is required for normal heart function after chronic pressure overload in mice. PLoS One (2014) 0.83

Postmenopausal hypertension and sodium sensitivity. J Menopausal Med (2014) 0.82

Autonomic contribution to endothelin-1 increase during laboratory anger-recall stress in patients with coronary artery disease. Mol Med (2011) 0.82

Depot-medroxyprogesterone acetate and endothelial function before and after acute oral, vaginal, and transdermal estradiol treatment. Hypertension (2011) 0.82

Impact of ovarian function on cardiovascular health in women: focus on hypertension. Int J Womens Health (2014) 0.81

Elevated serum concentrations of androgens in women with pregnancy-induced hypertension. Wien Klin Wochenschr (2003) 0.81

Pathological Importance of the Endothelin-1/ET(B) Receptor System on Vascular Diseases. Cardiol Res Pract (2012) 0.80

Effect of acute transdermal estrogen administration on basal, mental stress and cold pressor-induced sympathetic responses in postmenopausal women. Clin Auton Res (2005) 0.79

Orchidectomy enhances the expression of endothelin-1 and ETB receptors in rat portal vein. J Smooth Muscle Res (2014) 0.77

Effect of Breed on Plasma Endothelin-1 Concentration, Plasma Renin Activity, and Serum Cortisol Concentration in Healthy Dogs. J Vet Intern Med (2016) 0.77

Renal phenotype of ET-1 transgenic mice is modulated by androgens. Eur J Med Res (2009) 0.77

Aortic elastic properties in young pregnant women. Heart Vessels (2006) 0.75

Urinary biomarkers as indicator of chronic inflammation and endothelial dysfunction in obese adolescents. BMC Obes (2017) 0.75

Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases. Life Sci (2016) 0.75

Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skövde Cohort. BMC Cardiovasc Disord (2015) 0.75

Estrogen-induced improvement in coronary flow responses during atrial pacing in relation to endothelin-1 levels in postmenopausal women without coronary disease. Vasc Health Risk Manag (2008) 0.75

Androgen actions on endothelium functions and cardiovascular diseases. J Geriatr Cardiol (2016) 0.75

Themed section: endothelin. Br J Pharmacol (2013) 0.75

The Role of Endothelin System in Renal Structure and Function during the Postnatal Development of the Rat Kidney. PLoS One (2016) 0.75

Role of endothelin receptor antagonist; bosentan in cisplatin-induced nephrotoxicity in ovariectomized estradiol treated rats. J Nephropathol (2015) 0.75

Endothelin, sex, and pregnancy: unique considerations for blood pressure control in females. Am J Physiol Regul Integr Comp Physiol (2016) 0.75

Identifying "super responders" in pulmonary arterial hypertension. Pulm Circ (2017) 0.75

Articles by these authors

(truncated to the top 100)

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA (2001) 8.56

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol (1999) 7.15

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation (1999) 4.40

Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet (1986) 4.07

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia (1999) 3.60

Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet (1985) 3.13

Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. BJOG (2013) 2.83

A sex difference in the human brain and its relation to transsexuality. Nature (1995) 2.64

Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study. Circulation (1993) 2.62

Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male (2005) 2.60

Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol (1986) 2.58

Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol (2001) 2.42

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet (2000) 2.26

Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands. J Am Coll Cardiol (1989) 2.23

Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care (2001) 2.15

Serum testosterone levels are not elevated in patients with ankylosing spondylitis. J Rheumatol (1998) 2.09

Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol (1997) 2.05

Transsexualism: a review of etiology, diagnosis and treatment. J Psychosom Res (1999) 2.00

C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation (1997) 1.94

Comparison of seven immunoassays for the quantification of CA 125 antigen in serum. Clin Chem (1998) 1.90

Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) (1997) 1.90

A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol (1978) 1.85

Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome. Results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase. Circulation (1992) 1.73

[Clinical judgment and decision in practice. A patient with dyspnea]. Ned Tijdschr Geneeskd (1996) 1.71

ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study. J Intern Med (2009) 1.68

Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia (1999) 1.67

Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol (1997) 1.62

High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol (1999) 1.60

Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab (2000) 1.60

Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.60

Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA. Eur Heart J (2001) 1.58

Psychosocial factors and pregnancy outcome: a review with emphasis on methodological issues. J Psychosom Res (1995) 1.57

von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.57

Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly. Neurology (2001) 1.57

Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int (1998) 1.56

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol (2008) 1.55

Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries. Cardiovasc Res (1999) 1.54

Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis. J Am Coll Cardiol (1993) 1.53

Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck. J Nucl Med (2000) 1.52

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol (1999) 1.51

Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone. Andrologia (2008) 1.48

[Periodic fever due to hyper-IgD syndrome]. Ned Tijdschr Geneeskd (2000) 1.48

Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study. Circulation (2000) 1.46

Analysis of twenty-four-hour ambulatory blood pressure monitoring: what time period to assess blood pressures during waking and sleeping? J Hypertens (1995) 1.44

Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes (1997) 1.44

Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study. J Am Coll Cardiol (2001) 1.43

Birth order and sibling sex ratio in two samples of Dutch gender-dysphoric homosexual males. Arch Sex Behav (1996) 1.43

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol (1998) 1.42

Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation (1999) 1.42

Anticoagulation in pregnancy and the puerperium. Med J Aust (2001) 1.42

Effects of gonadal androgens and oestrogens on adrenal androgen levels. Clin Endocrinol (Oxf) (1995) 1.40

[Primary hyperaldosteronism as a cause of hypertension; diagnosis]. Ned Tijdschr Geneeskd (1996) 1.40

Reappearance of end-diastolic velocities in the umbilical artery following maternal volume expansion: a preliminary study. Obstet Gynecol (1992) 1.39

[Clinical judgment and decision making in clinical practice. A patient with fever and neck pain]. Ned Tijdschr Geneeskd (1996) 1.39

[Hormonal supplement therapy in women: effects on the cardiovascular system]. Ned Tijdschr Geneeskd (2001) 1.39

An epidemiological and demographic study of transsexuals in The Netherlands. Arch Sex Behav (1996) 1.38

Third degree obstetric perineal tears: risk factors and the preventive role of mediolateral episiotomy. Br J Obstet Gynaecol (1997) 1.35

Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev (2003) 1.35

Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation (1997) 1.35

The detection of granulocyte alloantibodies with an indirect immunofluorescence test. Br J Haematol (1977) 1.32

Memory for emotional events: differential effects of centrally versus peripherally acting beta-blocking agents. Psychopharmacology (Berl) (1998) 1.31

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl (2008) 1.31

Comparison of blood pressure measurement methods. Lancet (1997) 1.29

Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med (1997) 1.29

Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab (1994) 1.28

Psychosocial predictors of low birthweight: a prospective study. Br J Obstet Gynaecol (1999) 1.28

Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia (2010) 1.27

Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes (2000) 1.27

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl (2006) 1.26

Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarction. Am Heart J (1986) 1.25

Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab (2001) 1.25

ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res (2008) 1.22

Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am J Physiol (1999) 1.21

Left ventricular thrombus incidence and behavior studied by serial two-dimensional echocardiography in acute anterior myocardial infarction: left ventricular wall motion, systemic embolism and oral anticoagulation. J Am Coll Cardiol (1989) 1.21

Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatment. Am J Cardiol (1988) 1.19

A genome-wide scan for preeclampsia in the Netherlands. Eur J Hum Genet (2001) 1.17

The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update (2012) 1.16

Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands. Br Heart J (1988) 1.16

Risk factors for small-for-gestational-age infants by customised birthweight centiles: data from an international prospective cohort study. BJOG (2010) 1.16

Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides. Int J Cancer (2000) 1.15

In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab (2000) 1.14

Increased plasma homocysteine after menopause. Atherosclerosis (2000) 1.14

The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care (1998) 1.14

The prevalence of transsexualism in The Netherlands. Acta Psychiatr Scand (1993) 1.13

Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction. A randomized trial conducted by The Netherlands Interuniversity Cardiology Institute. Am J Cardiol (1987) 1.13

Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension (2001) 1.13

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly. Neurology (2000) 1.12

Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. Eur J Cancer (1996) 1.11

[Additional effects of statins independent of the cholesterol-lowering as yet not shown to be clinically relevant]. Ned Tijdschr Geneeskd (2000) 1.10

Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology (1991) 1.10

Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. Am J Cardiol (1993) 1.10

Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol (2001) 1.09

Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia (1998) 1.08

Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? Circulation (1986) 1.08

Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling. Circulation (1994) 1.08

Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions. Cardiovasc Res (2001) 1.07

Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid? J Reprod Immunol (2000) 1.07

Determinants of the limits of agreement between the sphygmomanometer and the SpaceLabs 90207 device for blood pressure measurement in health volunteers and insulin-dependent diabetic patients. J Hypertens (1998) 1.07

Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. Br J Cancer (1995) 1.07

Menopausal status and risk factors for cardiovascular disease. J Intern Med (1999) 1.05